SAN FRANCISCO — The EyeArt artificial intelligence eye screening system showed high sensitivity and high specificity for diabetic retinopathy in a pivotal multicenter clinical trial, according to a speaker here.
“I don’t need to introduce to this audience the impact of diabetes and diabetic blindness around the world. We recognize if we could detect it early and intervene in a timely fashion, it could largely be prevented, but there are many barriers out there to screening,” SriniVas Sadda, MD, said at the American Academy of Ophthalmology annual meeting.
While some
Uncategorized